These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 22353463)
21. Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model. Ranea-Robles P; Galino J; Espinosa L; Schlüter A; Ruiz M; Calingasan NY; Villarroya F; Naudí A; Pamplona R; Ferrer I; Beal MF; Portero-Otín M; Fourcade S; Pujol A Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12747. PubMed ID: 34237158 [TBL] [Abstract][Full Text] [Related]
22. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hein S; Schönfeld P; Kahlert S; Reiser G Hum Mol Genet; 2008 Jun; 17(12):1750-61. PubMed ID: 18344355 [TBL] [Abstract][Full Text] [Related]
23. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Singh A; Kukreti R; Saso L; Kukreti S Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. McGuinness MC; Zhang HP; Smith KD Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822 [TBL] [Abstract][Full Text] [Related]
26. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy. Deon M; Sitta A; Barschak AG; Coelho DM; Terroso T; Schmitt GO; Wanderley HY; Jardim LB; Giugliani R; Wajner M; Vargas CR J Neurol Sci; 2008 Mar; 266(1-2):79-83. PubMed ID: 17915255 [TBL] [Abstract][Full Text] [Related]
27. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. López-Erauskin J; Galino J; Bianchi P; Fourcade S; Andreu AL; Ferrer I; Muñoz-Pinedo C; Pujol A Brain; 2012 Dec; 135(Pt 12):3584-98. PubMed ID: 23250880 [TBL] [Abstract][Full Text] [Related]
28. Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy. Launay N; Lopez-Erauskin J; Bianchi P; Guha S; Parameswaran J; Coppa A; Torreni L; Schlüter A; Fourcade S; Paredes-Fuentes AJ; Artuch R; Casasnovas C; Ruiz M; Pujol A Brain; 2024 Jun; 147(6):2069-2084. PubMed ID: 38763511 [TBL] [Abstract][Full Text] [Related]
29. Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy. Launay N; Ruiz M; Fourcade S; Schlüter A; Guilera C; Ferrer I; Knecht E; Pujol A Brain; 2013 Mar; 136(Pt 3):891-904. PubMed ID: 23436506 [TBL] [Abstract][Full Text] [Related]
30. Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy. Deon M; Marchetti DP; Donida B; Wajner M; Vargas C Cell Mol Neurobiol; 2016 May; 36(4):497-512. PubMed ID: 26169524 [TBL] [Abstract][Full Text] [Related]
32. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy. Coppa A; Guha S; Fourcade S; Parameswaran J; Ruiz M; Moser AB; Schlüter A; Murphy MP; Lizcano JM; Miranda-Vizuete A; Dalfó E; Pujol A Free Radic Biol Med; 2020 May; 152():797-809. PubMed ID: 32017990 [TBL] [Abstract][Full Text] [Related]
33. Thermogenic flux induced by lignoceric acid in peroxisomes isolated from HepG2 cells and from X-adrenoleukodystrophy and control fibroblasts. Petroni A; Paroni R; Aloisi AM; Blasevich M; Haman N; Fessas D J Cell Physiol; 2019 Aug; 234(10):18344-18348. PubMed ID: 30932193 [TBL] [Abstract][Full Text] [Related]
34. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy. Morató L; Ruiz M; Boada J; Calingasan NY; Galino J; Guilera C; Jové M; Naudí A; Ferrer I; Pamplona R; Serrano M; Portero-Otín M; Beal MF; Fourcade S; Pujol A Cell Death Differ; 2015 Nov; 22(11):1742-53. PubMed ID: 25822341 [TBL] [Abstract][Full Text] [Related]
35. Cholesterol-deprivation increases mono-unsaturated very long-chain fatty acids in skin fibroblasts from patients with X-linked adrenoleukodystrophy. Engelen M; Ofman R; Mooijer PA; Poll-The BT; Wanders RJ; Kemp S Biochim Biophys Acta; 2008 Mar; 1781(3):105-11. PubMed ID: 18206987 [TBL] [Abstract][Full Text] [Related]
36. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
37. The X-linked adrenoleukodystrophy (X-ALD) and oxidative stress. Al-Omar MA J Herb Pharmacother; 2006; 6(3-4):125-34. PubMed ID: 17317654 [TBL] [Abstract][Full Text] [Related]
38. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency. Abe Y; Honsho M; Nakanishi H; Taguchi R; Fujiki Y Biochim Biophys Acta; 2014 Apr; 1841(4):610-9. PubMed ID: 24418004 [TBL] [Abstract][Full Text] [Related]
39. Pro- and Antioxidant Functions of the Peroxisome-Mitochondria Connection and Its Impact on Aging and Disease. Pascual-Ahuir A; Manzanares-Estreder S; Proft M Oxid Med Cell Longev; 2017; 2017():9860841. PubMed ID: 28811869 [TBL] [Abstract][Full Text] [Related]
40. [From gene to disease; X-linked adrenoleukodystrophy]. Engelen M; Kemp S; van Geel BM Ned Tijdschr Geneeskd; 2008 Apr; 152(14):804-8. PubMed ID: 18491823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]